Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2026-04-23 06:00 am | N/A 2033-04-14 | CASI Pharmaceuticals Inc. | CASIF | Folinsbee Thomas Director | 0 | $0 | 53,693 (Direct) | View |
Ownership | 2026-04-20 9:33 pm | N/A 2033-04-14 | CASI Pharmaceuticals Inc. | CASIF | Zeng Xuebo Director | 0 | $0 | 33,693 (Direct) | View |
Ownership | 2026-04-16 4:30 pm | N/A 2031-06-18 | CASI Pharmaceuticals Inc. | CASIF | Gao Wei R General Counsel | 0 | $0 | 84,000 (Direct) | View |
Ownership | 2026-04-13 4:30 pm | N/A 2032-03-20 | CASI Pharmaceuticals Inc. | CASIF | Qian Kun Global Controller | 0 | $0 | 75,000 (Direct) | View |
Ownership | 2026-04-07 4:30 pm | N/A 2034-01-29 | CASI Pharmaceuticals Inc. | CASIF | Huang Hai Global Chief Commercial Ofcr | 0 | $0 | 280,000 (Direct) | View |
Ownership | 2026-04-03 4:30 pm | N/A 2028-03-19 | CASI Pharmaceuticals Inc. | CASIF | Wang Chunhua Chief Operating Officer | 0 | $0 | 235,000 (Direct) | View |
Ownership | 2026-04-03 4:30 pm | N/A 2027-04-20 | CASI Pharmaceuticals Inc. | CASIF | Zukiwski Alexander A Global Chief Medical Officer | 0 | $0 | 116,333 (Direct) | View |
Ownership | 2026-03-27 08:19 am | N/A 2034-09-01 | CASI Pharmaceuticals Inc. | CASIF | Krebs-Pohl Barbara Helene Hannelore Director | 0 | $0 | 20,000 (Direct) | View |
Ownership | 2026-03-25 07:36 am | N/A N/A | CASI Pharmaceuticals Inc. | CASIF | Wu Alex Director | 0 | $0 | 139,310 (Direct) | View |
Ownership | 2026-03-18 7:06 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASIF | He Wei-Wu Director 10% Owner | 0 | $0 | 4,285,535 (Direct) | View |
Ownership | 2026-03-18 4:30 pm | N/A N/A | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 0 | $0 | 4,651,527 (Indirect) | View |